Nextgen Bio Meds Development And Gmp Consulting Llp - Company Profile

It is a information technology limited liability partnership based in Tirumalagiri, Telangana, India, established in 2022.
2022 Tirumalagiri, Telangana, India Struck Off
Last Updated:
About Nextgen Bio Meds Development And Gmp Consulting Llp

Nextgen Bio Meds Development And Gmp Consulting Llp, a struck off limited liability partnership, was established on 19 October 2022 in Tirumalagiri, Telangana, India. Engaging in computer related activities within the information technology sector, it holds LLPIN: ABC-8073. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Singroha Kanika (Designated Partner), Rajeev Chandra Paliwal (Designated Partner). It is based at 32-70/14/1A, Bank Colony, Neredmet, Hyderabad, Tirumalagiri, Telangana, 500056.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABC-8073

  • Incorporation Date

    19 October 2022

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 3 Year, 4 Months
Company report

Nextgen Bio Meds Development And Gmp Consulting Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nextgen Bio Meds Development And Gmp Consulting Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nextgen Bio Meds Development And Gmp Consulting Llp?
Current Designated Partners
Name Designation Appointment Date Status
Singroha Kanika Designated Partner 19 Oct 2022 Current
Rajeev Chandra Paliwal Designated Partner 19 Oct 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nextgen Bio Meds Development And Gmp Consulting Llp.

Enhance accessibility to Nextgen Bio Meds Development And Gmp Consulting Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nextgen Bio Meds Development And Gmp Consulting Llp revenue growth over time
Nextgen Bio Meds Development And Gmp Consulting Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nextgen Bio Meds Development And Gmp Consulting Llp?

Unlock access to Nextgen Bio Meds Development And Gmp Consulting Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nextgen Bio Meds Development And Gmp Consulting Llp?

Unlock and access historical data on people associated with Nextgen Bio Meds Development And Gmp Consulting Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nextgen Bio Meds Development And Gmp Consulting Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextgen Bio Meds Development And Gmp Consulting Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nextgen Bio Meds Development And Gmp Consulting Llp
Recent Activity within the Organization
  • Director Appointment

    The activity Singroha Kanika was appointed as a Designated Partner was appointed as a Designated Partner on 19 Oct 2022 & has been associated with this company since 3 years 4 months . was completed.

  • Director Appointment

    Rajeev Chandra Paliwal was appointed as a Designated Partner was appointed as a Designated Partner on 19 Oct 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on Nextgen Bio Meds Development And Gmp Consulting Llp was registered on 19 Oct 2022 with Roc Hyderabad & aged 3 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Nextgen Bio Meds Development And Gmp Consulting Llp?

The LLPIN of Nextgen Bio Meds Development And Gmp Consulting Llp is ABC-8073.

Where is Nextgen Bio Meds Development And Gmp Consulting Llp headquartered?

Nextgen Bio Meds Development And Gmp Consulting Llp is headquartered at 32-70/14/1A, Bank Colony, Neredmet, Hyderabad, Tirumalagiri, Telangana, 500056.

When was Nextgen Bio Meds Development And Gmp Consulting Llp incorporated?

Nextgen Bio Meds Development And Gmp Consulting Llp was incorporated on 19 October 2022.

Who are the current directors of Nextgen Bio Meds Development And Gmp Consulting Llp?

The current directors of Nextgen Bio Meds Development And Gmp Consulting Llp are

What is the primary industry of Nextgen Bio Meds Development And Gmp Consulting Llp?

The primary industry of Nextgen Bio Meds Development And Gmp Consulting Llp is Information Technology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available